In The News

In The News

International Business Times | February 5, 2017
Athletes who suffer a concussion show elevated levels of the protein tau in their blood, according to a new study published in Neurology last month ahead of Sunday's Super Bowl. Quanterix's Simoa technology is able to digitally parse through a wide range of substances, which allows it to find and…
Forbes | February 4. 2017
Taking advantage of ultrasensitive Simoa technology developed at Quanternix, researchers found that athletes who had a prolonged recovery after suffering a concussion had significantly higher levels of tau protein in their bloodstream at the sixth hour post injury compared with those players who…
News-Medical | February 3, 2017
An interview with Professor David Walt, Tufts University, conducted by April Cashin-Garbutt, MA
Bloomberg Businessweek | February 1, 2017
Quanterix is one of several life sciences companies racing for a way to diagnose CTE in the living.
Healio | January 26, 2017
Researchers and a biotechnology company are working toward making a test more readily available for clinicians to detect the protein tau in patients with brain injuries. Such a test would more accurately determine when athletes with head injuries can return to the playing field.
GenomeWeb | January 17, 2017
Many assessments for concussion rely on asking the injured person question like what year it is or who the president is, but researchers and companies are looking for ways to easily tease out biomarkers for concuss
Wired | January 17, 2017
“It’s like trying to find grains of sand in a thousand Olympic-size swimming pools,” says Jessica Gill, a researcher at the National Institutes of Health who studies brain trauma and PTSD in soldiers. “That’s why we hadn’t been looking for it, even though we always thought it was there.” But now,…
NPR Science Friday | January 13, 2017
NPR Science Friday segment featuring guests Jessica Gill and Robert Stern discussing new research that finds that levels of tau in the blood after a concussion correlate with how long it takes an athlete to return to play.
To view the live webcast of the presentation "The Next Frontier of Medicine," click 'read more'
360dx | January 9, 2017
Quanterix announced on Monday it and BioMérieux have signed a new licensing deal giving both firms greater flexibility to commercialize products within their respective fields.